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Protocol
AbstrACt
Introduction Rectal cancer affects more than 600 
patients per year in Wales, with a 5-year survival rate 
of around 60%. A recent report demonstrated that 19% 
of patients with bowel cancer had difficulty controlling 
their bowels after surgery, and these patients were twice 
as likely to report lower quality of life than those who 
had control. Nearly all patients will experience bowel 
dysfunction initially following surgery and up to 25% 
will experience severe bowel dysfunction on a long-term 
basis. The aim of this study is to test the feasibility of 
introducing a simple intervention in an attempt to improve 
bowel function following surgery for rectal cancer. We 
propose the introduction of an educational session from 
specialist nurses and physiotherapists prior to surgery and 
a subsequent physiotherapy programme for 3 months to 
teach patients how to strengthen their pelvic floor.
Methods and analysis All patients with rectal 
cancer planned to receive an anterior resection will be 
approached for the study. The study will take place in 
three centres over 12 months, and we expect to recruit 40 
patients. The primary outcome measure is the proportion 
of eligible patients approached who consent to and 
attend the educational session. The secondary outcomes 
include patient compliance to the pelvic floor rehabilitation 
programme (assessed by patient paper or electronic 
diary), the acceptability of the intervention to the patient 
(assessed using qualitative interviews) and preoperative 
and postoperative pelvic floor tone (assessed using the 
Oxford Grading System and the International Continence 
Society Grading System), patient bowel function 
and patient quality of life (assessed using validated 
questionnaires).
Ethics and dissemination Ethics approval was granted. 
This feasibility study is in progress. If patients find the 
intervention acceptable, the next stage would be a trial 
comparing outcomes after anterior resection in those who 
have and do not have physiotherapy.
trial registration number ISRCTN77383505; Pre-results.
IntroduCtIon 
Rectal cancer affects more than 600 patients 
per year in Wales, with an overall 5-year survival 
rate of around 60%.1 A recent report commis-
sioned by the Department of Health as part 
of the National Cancer Survivorship Initiative 
demonstrated that 19% of all patients with 
bowel cancer had difficulty controlling their 
bowels after surgery, and these patients 
were twice as likely to report lower quality of 
life (QoL) than those with control.2 Specif-
ically for rectal cancer, surgical resection 
with curative intent is the primary treatment 
for most patients. While more patients are 
avoiding a permanent stoma by having an 
anterior resection for rectal tumours, there 
is a tradeoff for patients in terms of their 
QoL due to bowel function.3 
The use of a temporary ileostomy to cover 
a pelvic anastomosis following anterior 
resection for a mid to low anastomosis is 
now considered standard practice for most 
colorectal surgeons in the UK and USA. 
The use of a temporary ileostomy reduces 
the mortality associated with an anastomotic 
leak.4 Standard timing for reversal is consid-
ered to be 3 months; however, there is limited 
evidence for optimal timings. A meta-analysis 
of four randomised controlled trials of early 
(<14 days) reversal of ileostomy has shown 
that early closure is both feasible and safe.5 
strengths and limitations of this study
 ► This study addresses a significant problem in aiming 
to improve bowel function of patients who have had 
rectal surgery.
 ► The intervention is simple, cheap and without risk 
of complication.
 ► For those patients not having neoadjuvant treatment, 
there is a limited time for recruitment, educational 
session and starting the pelvic floor rehabilitation 
programme prior to surgery,
 ► Patients may follow one of several pathways; those 
who have neoadjuvant treatment will have a longer 
preoperative period in the study. For those who have 
a defunctioning ileostomy, bowel continuity may 
not be restored by the end of the study period (3 
months) preventing full assessment of some of the 
secondary outcomes.
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However, in practice, reversal of ileostomy is a benign 
procedure without a cancer-driven target in the UK 
and as such may be delayed due to a variety of factors 
including patient recovery, postsurgical complications or 
chemoradiotherapy, as well as service demand pressures. 
Nearly all patients will experience bowel dysfunction 
initially following surgery and restoration of bowel conti-
nuity (if stoma reversed) for up to 12 months. However, 
a significant proportion of patients will experience long-
term bowel dysfunction. Studies looking at long-term 
follow-up after anterior resection syndrome (ARS) (1–13 
years) have reported rates of major bowel dysfunction of 
20%–56%.6–10
ARS was defined in 2012 as disordered bowel function 
after rectal resection, leading to a detriment in QoL.11 
The aetiology of ARS is thought to be multifactorial, with 
the potential of sphincter injury during the construction 
of the anastomosis, alterations in anorectal physiology 
and the development of a pudendal neuropathy.12 It has 
been shown that the presence of a temporary ileostomy 
is a risk factor for bowel dysfunction following anterior 
resection,13 14 and there is limited evidence from small 
studies that prolonged time to ileostomy closure is an 
independent risk factor for anterior resection syndrome, 
with earlier closure (less than 3–6 months) being protec-
tive.9 15 16 It may be postulated that prolonged inactivity 
of the pelvic floor and sphincter complex contributes to 
anterior resection syndrome.
Further work on functional bowel outcomes after ante-
rior resection has demonstrated that poorer outcome is 
associated with low tumours, pelvic sepsis following anasto-
motic leak and in those patients undergoing neoadjuvant 
and adjuvant radiotherapy.17 The symptoms are defined 
as part of low anterior resection syndrome (LARS) and 
include: faecal incontinence, urgency and frequency. We 
sent an evaluation of bowel function to all patients who 
had had a low anterior resection for rectal cancer in the 
University Hospital of Wales in a 6-year period. There was 
an 80% response rate (n=68). Thirty-eight patients (56%) 
had major LARS symptoms. Risk factors for the develop-
ment of LARS symptoms on regression analysis were the 
presence of a defunctioning ileostomy for more than 6 
months and neoadjuvant chemoradiotherapy.
There have been a limited number of studies assessing 
the impact of pelvic floor rehabilitation (PFR) in patients 
following anterior resection surgery for rectal cancer. 
Physiotherapy interventions are non-invasive and inex-
pensive, require no sophisticated equipment and have 
hardly any adverse effects. In addition, physiotherapy 
does not exclude any other form of treatment. PFR is 
designed to strengthen these muscles over a period of 
time. Evidence from pelvic floor studies for urinary incon-
tinence suggests a period of specific muscle training over 
several weeks is needed to gain muscle hypertrophy.18
A systematic review by Visser et al19 evaluated the effec-
tiveness of PFR in improving functional outcome. They 
were only able to include five studies with a total of 321 
patients, of which approximately 90% had undergone 
pelvic floor training.20–24 The authors concluded that use 
of PFR was associated with improved functional outcome 
and QoL; however, they felt that the studies were of 
limited design quality. These studies looked at the use of 
pelvic floor physiotherapy after reversal of the stoma to 
improve symptoms that were already present. Maris et al25 
performed a systematic review of several different 
methods of conservative management for bowel dysfunc-
tion following rectal resection. Seven of the studies inves-
tigated the use of PFR, with two using biofeedback alone. 
One study compared patients who received 15 sessions 
of PFR after stoma closure with a case-matched control 
group who did not.24 Pucciani et al23 reported that 23% 
(n=21) patients were symptom free after multimodal 
rehabilitation. The incontinence score decreased signifi-
cantly in patients having an anterior resection, and this 
was observed in both men (p<0.03) and women (p<0.02). 
Allgayer et al22 reported a highly significant effect of short-
term and long-term training on incontinence scores. 
Patients who had undergone radiotherapy improved to 
the same level, despite having a worse baseline inconti-
nence, greater stool frequency and higher use of antidiar-
rhoeal agents than non-irradiated patients. The majority 
of these studies involved small numbers, with even the 
three largest studies involving less than 100 patients.21–23
The aim of this study is to test the feasibility of intro-
ducing a simple intervention in an attempt to improve 
bowel function following surgery for rectal cancer. We 
propose the introduction of an educational session from 
specialist nurses and physiotherapists prior to surgery to 
teach patients how to strengthen their pelvic floor using 
this programme. The primary aim of this study is to 
see if the introduction of pelvic floor training is accept-
able to patients and if they are able to comply with the 
programme at what may be a stressful time for themselves 
and their family.
The use of a PFR programme in patients undergoing 
colorectal cancer surgery is not standard practice in the 
UK. We hope to initiate future studies to assess the impact 
of introducing this intervention on bowel function and 
the effect on QoL for bowel cancer survivors.
MEthods And AnAlysIs
study design
This is a single-arm, non-randomised, prospective feasi-
bility study assessing the acceptability of a physiother-
apy-based intervention (PFR programme) for patients 
undergoing anterior resection for rectal cancer in Cwm 
Taf and Cardiff and Vale University Health Boards. This 
feasibility study is already in progress having started in 
Cwm Taf in April 2016 and Cardiff and Vale in September 
2017. Recruitment is due to finish in November 2018.
study population
All patients with rectal cancer planned to receive an ante-
rior resection will be approached for the study. An ante-
rior resection may be defined as removal of part or all of 
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the rectum with an anastomosis of the two ends to allow 
bowel continuity.
Eligibility criteria
Inclusion criteria
 ► Diagnosed with rectal cancer.
 ► Planned anterior resection.
 ► Aged 18+ years of age.
 ► Able to provide informed consent.
 ► Suitable and capable of performing the PFR 
programme.
Exclusion criteria
 ► Unable to give informed consent.
 ► Not physically capable of performing the PFR 
programme.
IntErvEntIons
Educational session
After screening and consent, patients will attend a preop-
erative educational session. The educational sessions 
will take place in small gender-segregated groups where 
possible, but due to recruitment timelines and patient 
availability, some sessions will be one-to-one. The session 
will take approximately an hour. Baseline information 
regarding the patient’s demography, medical history 
(including bowel function), surgical history and current 
drug use will be collected. The patient will complete base-
line QoL and bowel function questionnaires. Patients will 
then be provided with an overview of normal anatomy 
and bowel function, how it is changed by surgery, ante-
rior resection syndrome and management and what the 
study involves.
Qualitative interview
A proportion of the sessions (6–10) will be observed by 
a qualitative researcher. Those that wish to participate in 
the interview with the qualitative interviewer to gather 
their opinions of the educational session can be inter-
viewed after the educational session or, if preferred, the 
researcher can interview the patient at home at an agreed 
time. The interviews will be undertaken individually. We 
expect to interview 6–10 participants.
PFr programme
Either on the same day or at a later date, patients will 
attend for baseline pelvic floor examination and introduc-
tion to PFR with the physiotherapist. They will be asked 
to start pelvic floor exercises immediately and to continue 
until their operation and to recommence the exercises 
as soon as they are able to after their operation. Median 
time from baseline assessment to surgery is 2 weeks for 
patients not having neoadjuvant treatment. Those who 
receive neoadjuvant therapy or who wait longer than 4 
weeks from baseline assessment to surgery will require an 
additional preoperative pelvic floor assessment and will 
be required to complete the bowel function and QoL 
questionnaires again 2 weeks before their surgery.
Patients will be asked to complete three sets of muscle 
exercises per day: fast pelvic floor contractions (10 repe-
titions three times per day), slow pelvic floor contractions 
(10 repetitions three times per day) and submaximal 
pelvic floor contraction (practice often throughout the 
day). Each set will take between 3 and 5 min to complete. 
They can be done at any time of the day, any location 
and performed in any position that is convenient and 
comfortable for the patient. Patients across sites will be 
shown the same educational presentation and given the 
same patient information/app to attempt to standardise 
the PFR programme.
Patients will attend two follow-up visits at 6–10 weeks 
and 3 months post-anterior resection for pelvic floor 
assessment and completion of bowel function and QoL 
questionnaires. At this point, patients with a temporary 
ileostomy may not yet have had it reversed, but they will 
not be required to attend any further follow-up. After 3 
months, patients will no longer be required to continue 
the pelvic floor programme as part of the study but can 
continue to if they wish based on their individual experi-
ence and any benefits they may have derived.
Those that have consented to qualitative interview 
will be contacted from 6 weeks postsurgery to partici-
pate in a follow-up interview. Again we expect to inter-
view 6–10 patients postoperatively on an individual 
basis, but these do not need to be the same patients that 
were interviewed preoperatively. The aim of the post-
operative interview is to explore how the participant 
found the pelvic floor exercises, the diary or app and 
the pelvic floor assessments to determine whether this 
PFR programme is acceptable and feasible.
All patients that expressed an interest in the focus 
group will be asked to attend a focus group in order to 
comment on a physiotherapy DVD and contribute to its 
development.
sample size estimation
Based on a previous service evaluation, it is anticipated 
that a minimum of 60 patients will have anterior resec-
tions performed at both participating sites during 
a period of 1 year. A minimum educational session 
attendance rate of 60% (36 patients) is projected. We 
expect to be able to recruit approximately 40 patients 
in 1 year. Recruitment will continue until 40 patients 
have attended an educational session or until the 1 year 
recruitment period is complete, whichever is first. All 
patients that have been approached for study participa-
tion will be allowed to continue, even if the 40th patient 
attendance has been achieved in the meantime.
outCoME AssEssMEnt
Primary outcome
The primary outcome is the proportion of patients 
approached who consent to and attend the educational 
session. A screening log will be kept of all eligible patients, 
those that are approached to participate in the study 
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and those who consent. For those that do not consent, 
a reason for refusal will be sought if possible and docu-
mented. An attendance log will be maintained for the 
educational session.
secondary outcomes
Patients’ compliance to the PFR programme will be 
assessed by reviewing the patient’s paper diary or Squeezy 
app log. The Squeezy app has been designed by chartered 
physiotherapists specialising in Women’s Health working 
in the National Health Service (NHS).26 Squeezy has been 
reviewed and approved by the NHS Choices health apps 
library team for its clinical safety and costs £2.99 (the cost 
of which is covered by the grant funding). The app can 
be tailored to a specific exercise programme by the phys-
iotherapists and set to remind patients when to do their 
exercises. It is simple to use, discreet, informative and has 
helpful visual and audio prompts to support the exercise 
programme. In addition, it maintains a prospective time 
record of the number of exercises completed, which can 
be reviewed by the physiotherapists. Patients will be given 
the option of recording their pelvic floor exercises with 
either a paper diary or Squeezy app.
The acceptability of the intervention will be assessed 
by interviewing a subset of the study population. A semi-
structured interview schedule has been created that 
will guide qualitative interviews but will also allow some 
freedom for the patient to discuss areas of importance to 
them. The schedules are tailored to whether the interview 
is posteducational session/preoperative or postoperative. 
Each group will include 6–10 individual interviews. The 
interview will be audio-recorded with the interviewee’s 
permission.
Pelvic floor tone will be assessed by one physiothera-
pist at each site. To standardise the assessment, validated 
grading systems will be used: the Oxford Grading System 
and the International Continence Society (ICS) Grading 
System. There are several scales of manual muscle testing 
in use worldwide for pelvic floor muscle (PFM) strength 
testing. The Oxford scale was chosen for this study, as 
it is a commonly used scale for PFM assessment among 
physiotherapists in the UK. Laycock and Jerwood27 have 
established intratherapist reliability of this scale, tested 
in bent-knee lying. Intertester reliability still needs to be 
established where two or more clinicians are involved in 
pretreatment and post-treatment assessment.28 To this 
effect, we have decided to also record muscle strength 
using the ICS grade as well. This is a validated tool29 and 
is used more frequently in international studies. This will 
not add time or additional testing for the patient but will 
allow an additional measure to be recorded for reliability 
and will aid the decision of which tool to use in future 
work.
Bowel function will be assessed with validated bowel 
function questionnaires. The LARS score is a simple 
five-question tool that was first created in 2012 in 
Denmark30 and has been validated for the English transla-
tion in 2014. The internationally validated score attempts 
to allow a uniform assessment of function in patients 
undergoing anterior resection.
The St Mark’s faecal incontinence tool was created in 
199831 and is a modified version of the more commonly 
used Wexner score32 for faecal incontinence.
QoL will be assessed with validated questionnaires. 
EuroQol-5D is a generic QoL tool that generates a single 
index value for health status with considerable potential 
for use in healthcare evaluation and economic analysis.33
Cancer-specific QoL will be assessed with the European 
Organization for Research and Treatment of Cancer core 
quality of life questionnaire (EORTC QLQ-C30) (V.3.0) 
and the quality of life questionnaire for patients with 
colorectal cancer (EORTC QLQ-CR29) (V.2.1).34 These 
instruments are frequently used and are internationally 
validated.
As an adjunct to this study, a video/DVD of the educa-
tional session and physiotherapy programme will be 
developed. Patients who have participated in the educa-
tional session will be invited to a focus group to comment 
on the DVD; its content, ease of use and their thoughts 
on its merits versus a one-to-one or group session with a 
nurse/physiotherapist. The focus group will be audio-re-
corded with the attendees’ permission.
data analysis
The number of patients approached as per screening log 
and the number of patients who attended the educational 
session according to the attendance log will be used to 
calculate attendance rate.
Compliance will be derived from the percentage 
completion of the practice of PFM exercises from the daily 
summary of the diary or app. With adequate numbers, 
comparisons will be undertaken of compliance rates for 
patients using the app versus those using paper diaries.
Bowel function and QoL measured at baseline 
(following neoadjuvant treatment if required), 6 weeks 
and 3 months postsurgery will be analysed using χ2 test 
and risk factors for LARS analysed using risk regression.
Interview data content analysis will be undertaken by 
the lead qualitative researcher using NVivo V.10 with 
double coding undertaken by a member of the research 
team with qualitative data analysis experience. The 
transcripts will be systematically analysed through the 
following stages:
 ► Preliminary reading: transcripts are read and reread 
by the qualitative researcher.
 ► Initial coding: line–line coding is conducted with 
initial descriptive comments noted.
 ► Identification and development of emergent patterns 
(themes): initial comments are grouped taking 
account for commonality and divergence. Themes 
are clustered according to inter-relationships, connec-
tions and patterns across themes.
 ► Subsequent transcripts: new themes are tested against 
previous cases as non-recurring themes are tested 
against following cases. Connections across cases are 
noted to identify a set of super-ordinate themes for the 
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participant cohort. A coding framework for emergent 
themes will be developed, validated and compared.
The quantitative data will inform what proportion 
of patients are willing to partake in the trial and their 
compliance to the programme. The qualitative interviews 
will help us to better understand reasons for patients 
not wanting to take part or failing to comply with the 
programme to help improve the programme for future 
patients and trials.
Management and safety
National Institute for Health and Care Excellence guid-
ance (CG171) states that PFR is not associated with any 
risks of complications specific to the treatment. However, 
all of the patients involved in the study will be undergoing 
major surgery, and there are risks associated with this, so 
it is likely that serious adverse events will occur within 
the study group. It is considered unlikely that any related 
serious adverse events will occur from the PFR itself. 
Serious adverse event reporting will commence from start 
of PFR to 7 days after the final pelvic floor physiotherapy 
assessment.
Patient and public involvement
Two lay representatives sat on the Trial Development 
Group. They reviewed the protocol and all patient-related 
materials to assess appropriate terminology and to ensure 
we are putting the patient at the centre of our research 
goals. Patients will be invited to request study results if 
interested.
EthICs And dIssEMInAtIon
The trial will be conducted in compliance with the princi-
ples of the Declaration of Helsinki (2013) and the princi-
ples of Good Clinical Practice and in accordance with all 
applicable regulatory guidance.
The intervention does include an intimate examination 
as part of the pelvic floor assessment. Participants must 
agree to this separately. Those who do not agree can still 
take part and undergo the rest of the pelvic floor assess-
ment. Following surgery, the rectal examination is only 
performed if agreed by the patient’s consultant to avoid 
stress on the anastomosis.
The study will respect the rights of participating patients 
and ensure confidentiality of patient information. Inter-
view data as well as diary data will be transcribed by a 
professional transcription company and will be stored 
on password-protected computers at the Swansea Trials 
Unit at Swansea University. Participants will be allocated 
an individual specific trial number, which will be used 
to identify their data. Participant’s personal details will 
be stored separately by sites under the guidelines of the 
1988 Data Protection Act and not entered onto the trial 
database. Personal data will not be kept for longer than is 
required for the purpose for which it has been acquired.
Patients undergoing surgery for colorectal cancer have 
an excellent support system through the specialist cancer 
nurses and the clinical team, as well as several charities 
and voluntary organisations. Should participants have 
additional questions about the trial, advice will be avail-
able from both within the research team and outside of 
the research team in the form of websites such as the NHS 
website's Clinical trials page: http://www. nhs. uk/ Condi-
tions/ Clinical- trials/ Pages/ Takingpart. aspx.
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